世界の加齢黄斑変性症用治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Age Related Macular Degeneration Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3771 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、加齢黄斑変性症用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルセンティス、アイリーア、アバスチン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・加齢黄斑変性症用治療の市場動向 ・企業の競争状況、市場シェア ・加齢黄斑変性症用治療の種類別市場規模と予測2016-2027（ルセンティス、アイリーア、アバスチン、その他） ・加齢黄斑変性症用治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・加齢黄斑変性症用治療の北米市場規模2016-2027（アメリカ、カナダ） ・加齢黄斑変性症用治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・加齢黄斑変性症用治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・加齢黄斑変性症用治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・加齢黄斑変性症用治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Regeneron Pharmaceuticals、Bayer HealthCare、Novartis、Roche、Kanghong Pharma） ・結論

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

Market Analysis and Insights: Global Age Related Macular Degeneration Treatment Market
The global Age Related Macular Degeneration Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Age Related Macular Degeneration Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Age Related Macular Degeneration Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Age Related Macular Degeneration Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Age Related Macular Degeneration Treatment market.

Global Age Related Macular Degeneration Treatment Scope and Market Size
Age Related Macular Degeneration Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Age Related Macular Degeneration Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lucentis
Eylea
Avastin
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Age Related Macular Degeneration Treatment Market Perspective (2016-2027)
2.2 Age Related Macular Degeneration Treatment Growth Trends by Regions
2.2.1 Age Related Macular Degeneration Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Age Related Macular Degeneration Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Age Related Macular Degeneration Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Age Related Macular Degeneration Treatment Industry Dynamic
2.3.1 Age Related Macular Degeneration Treatment Market Trends
2.3.2 Age Related Macular Degeneration Treatment Market Drivers
2.3.3 Age Related Macular Degeneration Treatment Market Challenges
2.3.4 Age Related Macular Degeneration Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Age Related Macular Degeneration Treatment Players by Revenue
3.1.1 Global Top Age Related Macular Degeneration Treatment Players by Revenue (2016-2021)
3.1.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Age Related Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Age Related Macular Degeneration Treatment Revenue
3.4 Global Age Related Macular Degeneration Treatment Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Treatment Revenue in 2020
3.5 Age Related Macular Degeneration Treatment Key Players Head office and Area Served
3.6 Key Players Age Related Macular Degeneration Treatment Product Solution and Service
3.7 Date of Enter into Age Related Macular Degeneration Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Age Related Macular Degeneration Treatment Breakdown Data by Type
4.1 Global Age Related Macular Degeneration Treatment Historic Market Size by Type (2016-2021)
4.2 Global Age Related Macular Degeneration Treatment Forecasted Market Size by Type (2022-2027)

5 Age Related Macular Degeneration Treatment Breakdown Data by Application
5.1 Global Age Related Macular Degeneration Treatment Historic Market Size by Application (2016-2021)
5.2 Global Age Related Macular Degeneration Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Age Related Macular Degeneration Treatment Market Size (2016-2027)
6.2 North America Age Related Macular Degeneration Treatment Market Size by Type
6.2.1 North America Age Related Macular Degeneration Treatment Market Size by Type (2016-2021)
6.2.2 North America Age Related Macular Degeneration Treatment Market Size by Type (2022-2027)
6.2.3 North America Age Related Macular Degeneration Treatment Market Size by Type (2016-2027)
6.3 North America Age Related Macular Degeneration Treatment Market Size by Application
6.3.1 North America Age Related Macular Degeneration Treatment Market Size by Application (2016-2021)
6.3.2 North America Age Related Macular Degeneration Treatment Market Size by Application (2022-2027)
6.3.3 North America Age Related Macular Degeneration Treatment Market Size by Application (2016-2027)
6.4 North America Age Related Macular Degeneration Treatment Market Size by Country
6.4.1 North America Age Related Macular Degeneration Treatment Market Size by Country (2016-2021)
6.4.2 North America Age Related Macular Degeneration Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Age Related Macular Degeneration Treatment Market Size (2016-2027)
7.2 Europe Age Related Macular Degeneration Treatment Market Size by Type
7.2.1 Europe Age Related Macular Degeneration Treatment Market Size by Type (2016-2021)
7.2.2 Europe Age Related Macular Degeneration Treatment Market Size by Type (2022-2027)
7.2.3 Europe Age Related Macular Degeneration Treatment Market Size by Type (2016-2027)
7.3 Europe Age Related Macular Degeneration Treatment Market Size by Application
7.3.1 Europe Age Related Macular Degeneration Treatment Market Size by Application (2016-2021)
7.3.2 Europe Age Related Macular Degeneration Treatment Market Size by Application (2022-2027)
7.3.3 Europe Age Related Macular Degeneration Treatment Market Size by Application (2016-2027)
7.4 Europe Age Related Macular Degeneration Treatment Market Size by Country
7.4.1 Europe Age Related Macular Degeneration Treatment Market Size by Country (2016-2021)
7.4.2 Europe Age Related Macular Degeneration Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration Treatment Market Size (2016-2027)
8.2 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Type
8.2.1 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Application
8.3.1 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region
8.4.1 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Age Related Macular Degeneration Treatment Market Size (2016-2027)
9.2 Latin America Age Related Macular Degeneration Treatment Market Size by Type
9.2.1 Latin America Age Related Macular Degeneration Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Age Related Macular Degeneration Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Age Related Macular Degeneration Treatment Market Size by Type (2016-2027)
9.3 Latin America Age Related Macular Degeneration Treatment Market Size by Application
9.3.1 Latin America Age Related Macular Degeneration Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Age Related Macular Degeneration Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Age Related Macular Degeneration Treatment Market Size by Application (2016-2027)
9.4 Latin America Age Related Macular Degeneration Treatment Market Size by Country
9.4.1 Latin America Age Related Macular Degeneration Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Age Related Macular Degeneration Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration Treatment Market Size (2016-2027)
10.2 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Type
10.2.1 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Application
10.3.1 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country
10.4.1 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Company Details
11.1.2 Regeneron Pharmaceuticals Business Overview
11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Introduction
11.1.4 Regeneron Pharmaceuticals Revenue in Age Related Macular Degeneration Treatment Business (2016-2021)
11.1.5 Regeneron Pharmaceuticals Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Details
11.2.2 Bayer HealthCare Business Overview
11.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Introduction
11.2.4 Bayer HealthCare Revenue in Age Related Macular Degeneration Treatment Business (2016-2021)
11.2.5 Bayer HealthCare Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Age Related Macular Degeneration Treatment Introduction
11.3.4 Novartis Revenue in Age Related Macular Degeneration Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Age Related Macular Degeneration Treatment Introduction
11.4.4 Roche Revenue in Age Related Macular Degeneration Treatment Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Kanghong Pharma
11.5.1 Kanghong Pharma Company Details
11.5.2 Kanghong Pharma Business Overview
11.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Introduction
11.5.4 Kanghong Pharma Revenue in Age Related Macular Degeneration Treatment Business (2016-2021)
11.5.5 Kanghong Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Age Related Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lucentis
Table 3. Key Players of Eylea
Table 4. Key Players of Avastin
Table 5. Key Players of Other
Table 6. Global Age Related Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Age Related Macular Degeneration Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Age Related Macular Degeneration Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Age Related Macular Degeneration Treatment Market Share by Regions (2016-2021)
Table 10. Global Age Related Macular Degeneration Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Age Related Macular Degeneration Treatment Market Share by Regions (2022-2027)
Table 12. Age Related Macular Degeneration Treatment Market Trends
Table 13. Age Related Macular Degeneration Treatment Market Drivers
Table 14. Age Related Macular Degeneration Treatment Market Challenges
Table 15. Age Related Macular Degeneration Treatment Market Restraints
Table 16. Global Age Related Macular Degeneration Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Age Related Macular Degeneration Treatment Market Share by Players (2016-2021)
Table 18. Global Top Age Related Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Treatment as of 2020)
Table 19. Ranking of Global Top Age Related Macular Degeneration Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Age Related Macular Degeneration Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Age Related Macular Degeneration Treatment Product Solution and Service
Table 23. Date of Enter into Age Related Macular Degeneration Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Age Related Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Age Related Macular Degeneration Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Age Related Macular Degeneration Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Age Related Macular Degeneration Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Age Related Macular Degeneration Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Age Related Macular Degeneration Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Age Related Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Age Related Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Age Related Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Age Related Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Age Related Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Age Related Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Age Related Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Age Related Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Age Related Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Age Related Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Age Related Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Age Related Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Age Related Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Age Related Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Age Related Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Age Related Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Age Related Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Age Related Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Regeneron Pharmaceuticals Company Details
Table 64. Regeneron Pharmaceuticals Business Overview
Table 65. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Product
Table 66. Regeneron Pharmaceuticals Revenue in Age Related Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 67. Regeneron Pharmaceuticals Recent Development
Table 68. Bayer HealthCare Company Details
Table 69. Bayer HealthCare Business Overview
Table 70. Bayer HealthCare Age Related Macular Degeneration Treatment Product
Table 71. Bayer HealthCare Revenue in Age Related Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 72. Bayer HealthCare Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Age Related Macular Degeneration Treatment Product
Table 76. Novartis Revenue in Age Related Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Age Related Macular Degeneration Treatment Product
Table 81. Roche Revenue in Age Related Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Kanghong Pharma Company Details
Table 84. Kanghong Pharma Business Overview
Table 85. Kanghong Pharma Age Related Macular Degeneration Treatment Product
Table 86. Kanghong Pharma Revenue in Age Related Macular Degeneration Treatment Business (2016-2021) & (US$ Million)
Table 87. Kanghong Pharma Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age Related Macular Degeneration Treatment Market Share by Type: 2020 VS 2027
Figure 2. Lucentis Features
Figure 3. Eylea Features
Figure 4. Avastin Features
Figure 5. Other Features
Figure 6. Global Age Related Macular Degeneration Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Age Related Macular Degeneration Treatment Report Years Considered
Figure 11. Global Age Related Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Age Related Macular Degeneration Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Age Related Macular Degeneration Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Age Related Macular Degeneration Treatment Market Share by Regions (2022-2027)
Figure 15. Global Age Related Macular Degeneration Treatment Market Share by Players in 2020
Figure 16. Global Top Age Related Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration Treatment Revenue in 2020
Figure 18. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Age Related Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 22. North America Age Related Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 23. North America Age Related Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 24. United States Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Age Related Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 28. Europe Age Related Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 29. Europe Age Related Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 30. Germany Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Age Related Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Age Related Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Age Related Macular Degeneration Treatment Market Share by Region (2016-2027)
Figure 40. China Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Age Related Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Age Related Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Age Related Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Age Related Macular Degeneration Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Age Related Macular Degeneration Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Age Related Macular Degeneration Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Age Related Macular Degeneration Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2016-2021)
Figure 60. Bayer HealthCare Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2016-2021)
Figure 63. Kanghong Pharma Revenue Growth Rate in Age Related Macular Degeneration Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---